Bold claim first: scientists are expanding the color palette of biomedicine by revolutionizing how amino acids are made and used in peptides. And here’s why that matters—and where it could spark debate.
A research team at UC Santa Barbara has developed a streamlined method to synthesize non-natural amino acids and apply them directly to peptide construction. Published in the Journal of the American Chemical Society, their approach aims to give researchers broader access to amino acids beyond the 22 that occur naturally.
“The standout benefit is that the produced amino acids arrive ready-to-use for peptide synthesis, without the extra modification steps typically needed,” explains first author Phil Kohnke, a PhD student in Liming Zhang’s chemistry and biochemistry lab. “Compared with existing methods, this is one of the most straightforward and broadly useful strategies we’ve seen.”
The basics: what amino acids and peptides are
Amino acids are the building blocks of proteins, making them among biology’s most essential molecules. When 10 to 50 amino acids join, they form a peptide; longer chains form proteins, which can be more complex and sometimes composed of multiple peptides.
Like stacking cups, these units must connect in a specific orientation: one amino group links to a neighboring carboxyl group. The sequence of amino acids is what gives each peptide or protein its unique properties, much like the color pattern produced by arranging cups in a certain order.
Out of hundreds of amino acids that exist, life typically uses 22 to assemble proteins—20 canonical ones coded by our DNA, plus two that arise through other processes. Nature uses these 22 with remarkable success, but scientists want more options for designing new therapies and materials.
While natural amino acids are inexpensive to produce, the UCSB team has developed an efficient chemical route to non-natural amino acids that are immediately usable for peptide synthesis, removing several bottlenecks in traditional methods.
A two-step technique with a resin scaffold
Their method unfolds in two main steps: first, they synthesize non-natural amino acids using a gold-catalyzed process that starts from cheap, readily available chemicals. The second step assembles these amino acids into peptides on a resin scaffold, a solid support that lets researchers build chains in a rinse-and-repeat fashion.
A key advantage is stereoselectivity—the ability to produce amino acids with a defined handedness, avoiding undesired mixtures of mirror-image forms. This precision is crucial for the biological activity and stability of the resulting peptides.
The resin approach simplifies purification too. Traditional peptide synthesis often involves purifying the target molecule from solution after each step; with resin, the growing chain remains attached to the scaffold and can be washed cleanly, with the final product cleaved off when ready. The researchers note that their method can be integrated into standard resin-based workflows with minimal friction.
Why this broadens possibilities
Having access to a wider array of amino acids opens new vistas for biochemists, medical researchers, and materials scientists. It’s akin to moving from a 22-color box of crayons to a palette with hundreds of hues, enabling finer control over how peptides fold and interact with targets.
Producing non-natural amino acids is often a hurdle—costly, time-consuming, or limited to narrow sets of compounds. The new technique addresses these drawbacks by delivering many amino acids that are ready for peptide synthesis without extra steps.
Zhang’s group is especially interested in advancing peptide therapeutics. Peptides have been used in more than 80 drugs since insulin’s breakthrough in the 1920s, but natural peptides can be fragile and prone to enzymatic degradation in the body. Incorporating non-natural amino acids can help peptides resist breakdown or adopt shapes that improve receptor binding. Ozempic, for example, relies on a non-natural amino acid alongside a fatty acid side chain to achieve its effects.
Looking ahead: automation and broader collaboration
The team is moving toward automating the process and, importantly, making these amino acids accessible to non-chemists. They are seeking partnerships to integrate this workflow into drug development and materials research, lowering barriers to adoption.
Bottom line: a promising advance with practical implications
This work offers a practical route to a much larger set of building blocks for peptide design, with potential to accelerate discovery in therapeutics and beyond. It prompts thought-provoking questions: should the scientific community embrace rapid, broad access to non-natural amino acids even as we consider safety and regulatory implications? How might automation change who can participate in peptide drug development? If you have a view on these points, share your thoughts in the comments.
